Amy Mahery is transformational biopharmaceutical industry leader recognized for driving advanced strategies to deliver growth across multibillion-dollar product portfolios. Amy is currently SVP, Head of the Global Business Franchise, Neurology and Immunology (N&I) at EMD Serono. where she leads all aspects of strategy for the N&I portfolio across the entire product life cycle from pipeline to marketed and mature products. Amy leads the Therapeutic Area Strategy and Execution Leadership Team and serves as a member of the Chief Marketing Officer Leadership Team, International Leadership Team, and Diversity Council. Her biopharma experience spans across global pipeline development, franchise strategy, M&A due diligence, and C-level advisory. She has a diverse combination of local and global market access, sales, and marketing leadership experience. Amy is a graduate of Trinity College -Hartford and has a degree in Neuroscience.
Bringing in market access and collaboration earlier in the process, viewing reimbursement as the last leg of the drug developmental journey, and collaborating across key functions are practices we can evolve so that as many patients as possible can reap the rewards that are waiting for them.